Regenerative Medical Technology (RMTG) Intangibles (2021 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Intangibles of $487700.0 for Q1 2026, up 262.28% year-over-year from $134619.0 in Q1 2025, and little changed quarter-over-quarter from $487700.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Intangibles (2021 - 2026) Analysis & Trends
Regenerative Medical Technology's Intangibles history runs 6 years deep, the most recent figure standing at $487700.0 for Q1 2026.
- In Q1 2026, Intangibles rose 262.28% year-over-year to $487700.0; the TTM figure through Mar 2026 stood at $487700.0 (up 262.28% YoY), while the FY2025 annual figure was $487700.0, up 206.72% from the prior year.
- Intangibles for Q1 2026 stood at $487700.0, roughly flat from $487700.0 in the prior quarter.
- The five-year high for Intangibles was $487700.0 in Q1 2022, with the low at $85849.0 in Q3 2025.
- The 5-year median for Intangibles is $329699.0 (2023), against an average of $333848.8.
- The sharpest annual moves came in 2025 and 2026: Intangibles slumped 82.4% in 2025, then surged 262.28% in 2026.
- Regenerative Medical Technology's Intangibles stood at $354084.0 in 2022, then fell by 27.55% to $256544.0 in 2023, then slumped by 38.02% to $159004.0 in 2024, then soared by 206.72% to $487700.0 in 2025, then changed by 0.0% to $487700.0 in 2026.
- Business Quant data shows RMTG's Intangibles at $487700.0 in Q1 2026, $487700.0 in Q4 2025, and $85849.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 487,700.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 487,700.00 |
| Dec 31, 2025 | 487,700.00 |
| Sep 30, 2025 | 85,849.00 |
| Jun 30, 2025 | 487,700.00 |
| Mar 31, 2025 | 134,619.00 |
| Dec 31, 2024 | 159,004.00 |
| Sep 30, 2024 | 487,700.00 |
| Jun 30, 2024 | 207,774.00 |
| Mar 31, 2024 | 232,159.00 |
| Dec 31, 2023 | 256,544.00 |
| Sep 30, 2023 | 280,929.00 |
| Jun 30, 2023 | 305,314.00 |
| Mar 31, 2023 | 329,699.00 |
| Dec 31, 2022 | 354,084.00 |
| Sep 30, 2022 | 487,700.00 |
| Jun 30, 2022 | 403,255.00 |
| Mar 31, 2022 | 487,700.00 |
| Dec 31, 2021 | 487,700.00 |
| Sep 30, 2021 | 487,700.00 |